The factsheet draws out connections between the disproportionate impact of HIV on women, gender inequality and economic empowerment. Using case studies from STOPAIDS members, the factsheet highlights the importance of meaningfully involving women, addressing structural barriers, transforming gender norms, closely involving the wider community, funding existing community groups to ensure sustainability.
This factsheet takes a life course approach and considers how biological, behavioural, social and structural factors during adolescence and early adulthood influence HIV outcomes and effective HIV programming strategies.
Entitled “Increasing DFID’s contribution to Addressing HIV among key populations” and building on our earlier critique of DFID’s position paper on HIV and AIDS, the report makes a series of recommendations about how STOPAIDS members believe DFID can work more effectively to advance the rights of communities who are disproportionately affected by AIDS, notably men who … Continued
A one-day seminar was held on 3rd April 2014 to mark 10 years of work by the STOPAIDS Children Affected by HIV and AIDS (CABA) working group. Despite encouraging global progress in promoting and protecting the rights of children and young people living with or affected by HIV, worrying gaps remain. Participants and presenters from across the international development, HIV … Continued
STOPAIDS has spent a large part of its time over the last three years campaigning for an increase in the UK’s contribution to the replenishment of the Global Fund to Fight AIDS, Tuberculosis and Malaria. In September 2013, the Secretary of State for International Development, Justine Greening, announced a better-than-doubling contribution of up to £1billion. … Continued
This factsheet explores harm reduction, effective interventions and outlines recommendations for the UK government. Harm reduction aims to reduce the health and social harms associated with drug use through a range of interventions and has been shown to be cost effective in preventing HIV infection among people who inject drugs.